### 61362 Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices

initiatives designed to improve the effectiveness of federal government operations. The meeting will also cover planning and logistics for PMAB during the coming year.

Meeting Access: The teleconference meeting is open to the public; interested members of the public may listen to the PMAB discussion using 1–888–673– 9806 and pass code 7836092. Members of the public will not have the opportunity to ask questions or otherwise participate in the teleconference. However, members of the public wishing to comment should follow the steps detailed in Procedures for Providing Public Comments below.

Availability of Materials for the Meeting: Please see the PMAB Web site (http://www.whitehouse.gov/ administration/advisory-boards/pmab) for any materials available in advance of the meeting and for meeting minutes that will be made available after the meeting. Detailed meeting minutes will be posted within 90 days of the meeting.

Procedures for Providing Public Comments: In general, public statements will be posted on the PMAB Web site (see above). Non-electronic documents will be made available for public inspection and copying in PMAB offices at GSA, 1800 F Street NW., Washington, DC 20006, on official business days between the hours of 10 a.m. and 5 p.m. eastern time. You can make an appointment to inspect statements by telephoning 202–501–1398. All statements, including attachments and other supporting materials, received are part of the public record and subject to public disclosure. Any statements submitted in connection with the PMAB meeting will be made available to the public under the provisions of the Federal Advisory Committee Act (FACA).

The public is invited to submit written statements for this meeting until 12:30 p.m. eastern time on Friday, October 18, 2013, by either of the following methods: Electronic or Paper Statements: Submit electronic statements to Mr. Brockelman, Designated Federal Officer at stephen.brockelman@gsa.gov; or send paper statements in triplicate to Mr. Brockelman at the PMAB GSA address above.

Dated: September 27, 2013. Anne Rung, Associate Administrator, Office of Government-wide Policy, General Services Administration.
[FR Doc. 2013–24145 Filed 10–2–13; 8:45 am]

**BILLING CODE 6820–BR–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Advisory Council on Alzheimer’s Research, Care, and Services; Meeting** 

**AGENCY :**  Assistant Secretary for Planning and Evaluation, HHS.

**ACTION :**  Notice of meeting.

**SUMMARY :**  This notice announces the public meeting of the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council). The Advisory Council on Alzheimer’s Research, Care, and Services provides advice on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. During the October meeting, the Advisory Council will welcome new members and discuss the timeline for the 2014 recommendations. The subcommittees will discuss priorities and areas for recommendations. The Advisory Council will hear presentations on work underway to harness ‘‘big data’’ to address Alzheimer’s research.

**DATES :**  The meeting will be held on October 28, 2013 from 9:00 a.m. to 5:00 p.m. EDT.

**ADDRESSES :**  The meeting will be held in the Great Hall of the U.S. Department of Health and Human Services, 200 Independence Avenue SW., Washington, DC 20201.

Comments: Time is allocated on the agenda to hear public comments. In lieu of oral comments, formal written comments may be submitted for the record to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW., Room 424E, Washington, DC 20201. Comments may also be sent to napa@ hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations.

**FOR FURTHER INFORMATION CONTACT :**  Helen Lamont, Ph.D. (202) 690–7996, helen.lamont@hhs.gov. Note: Seating may be limited. Those wishing to attend the meeting must send an email to napa@hhs.gov and put ‘‘October 28 meeting attendance’’ in the Subject line by Friday, October 18, 2013, so that their names may be put on a list of expected attendees and forwarded to the security officers at the Department of Health and Human Services. Any interested member of the public who is a non-U.S. citizen should include this information at the time of registration to ensure that the appropriate security procedure to gain entry to the building is carried out. Although the meeting is open to the public, procedures governing security and the entrance to Federal buildings may change without notice. If you wish to make a public comment, you must note that within your email.

**SUPPLEMENTARY INFORMATION :**  Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: The Advisory Council will welcome new members and discuss the timeline for the 2014 recommendations. The subcommittees will discuss priorities and areas for recommendations. The Advisory Council will hear presentations on work underway to harness ‘‘big data’’ to address Alzheimer’s research.

Procedure and Agenda: This meeting is open to the public.

Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees.

Dated: October 1, 2013. Donald Moulds, Acting Assistant Secretary for Planning and Evaluation.
[FR Doc. 2013–24206 Filed 10–2–13; 8:45 am]

**BILLING CODE P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Agency for Healthcare Research and Quality** 

**Notice of Meetings**

**AGENCY :**  Agency for Healthcare Research and Quality (AHRQ), HHS.

**ACTION :**  Notice of Five AHRQ Subcommittee Meetings.

**SUMMARY :**  The subcommittees listed below are part of AHRQ’s Health Services Research Initial Review Group Committee. Grant applications are to be reviewed and discussed at these meetings. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. These meetings will be closed to the public in accordance with 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6).

**DATES :**  See below for dates of meetings:

1. Healthcare Effectiveness and

Outcomes Research (HEOR) Date: October 16, 2013 (Open from

8:00 a.m. to 8:30 a.m. on October 16 and closed for remainder of the meeting)
2. Health System and Value Research

(HSVR)


### 61363 Federal Register / Vol. 78, No. 192 / Thursday, October 3, 2013 / Notices

Date: October 16, 2013 (Open from

8:00 a.m. to 8:30 a.m. on October 16 and closed for remainder of the meeting)
3. Health Care Research and Training

(HCRT) Date: October 17–18, 2013 (Open from

8:00 a.m. to 8:30 a.m. on on October 17 and closed for remainder of the meeting)
4. Healthcare Safety and Quality

Improvement Research (HSQR) Date: October 23–24, 2013 (Open from

8:00 a.m. to 8:30 a.m. on October 23 and closed for remainder of the meeting)
5. Healthcare Information Technology

Research (HITR) Date: October 31—November 1, 2013

(Open from 8:00 a.m. to 8:30 a.m. on October 31 and closed for remainder of the meeting)

**ADDRESSESS :**  The five meetings will take place at the following location: Hyatt Regency Hotel Bethesda, One Metro Center, Bethesda, MD 20814.

**FOR FURTHER INFORMATION CONTACT :**  (To obtain a roster of members, agenda or minutes of the non-confidential portions of the meetings.) Mrs. Bonnie Campbell, Committee Management Officer, Office of Extramural Research Education and Priority Populations, AHRQ, 540 Gaither Road, Suite 2000, Rockville, Maryland 20850, Telephone (301) 427–
1554.

**SUPPLEMENTARY INFORMATION :**  In accordance with section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. 2), AHRQ announces meetings of the scientific peer review groups listed above, which are subcommittees of AHRQ’s Health Services Research Initial Review Group Committee. Each subcommittee meeting will commence in open session before closing to the public for the duration of the meeting. The subcommittee meetings will be closed to the public in accordance with the provisions set forth in 5 U.S.C. App. 2 section 10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6) The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

Agenda items for these meetings are subject to change as priorities dictate.

Dated: September 25, 2013. Richard Kronick,

Director.
[FR Doc. 2013–24178 Filed 10–2–13; 8:45 am]

**BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND**  **HUMAN SERVICES**

**Agency for Healthcare Research and Quality** 

**Correction—Scientific Information Request on Medication Therapy**  **Management**

The original date of publication for this Federal Register notice was September 17, 2013, 78 FR 57159. On this publication, the Web site that appears under **ADDRESSES** is incorrect in page 57159. The correct Web site is: http://effectivehealthcare.AHRQ.gov/index.cfm/submit-scientificinformation-packets/

Dated: September 27, 2013. Richard Kronick, AHRQ Director.
[FR Doc. 2013–24182 Filed 10–2–13; 8:45 am]

**BILLING CODE 4160–90–P**

**DEPARTMENT OF HEALTH AND HUMAN SERVICES** 

**Centers for Disease Control and Prevention** 

**[60Day–13–0787]**

**Proposed Data Collections Submitted for Public Comment and**  **Recommendations**

In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention (CDC) will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404–639–7570 or send comments to LeRoy Richardson, at CDC 1600 Clifton Road, MS–D74, Atlanta, GA 30333 or send an email to omb@ cdc.gov

.

Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project

Personal Flotation Devices (PFDs) and Commercial Fishermen: Preconceptions and Evaluation in Actual Use— Reinstatement with Change—(OMB Number 0920–0787, expiration date 8/ 31/2010) National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC). Background and Brief Description

NIOSH has the responsibility under Pub. L. 91–596 section 20 (Occupational Safety and Health Act of 1970) to conduct research relating to innovative methods, techniques, and approaches for dealing with occupational safety and health problems.

Commercial fishing is one of the most dangerous occupations in the United States, with a fatality rate 30 times higher than the national average. Most fishermen who die on the job drown subsequent to a vessel sinking (52%) or fall overboard (31%). Because drowning is the leading cause of death for commercial fishermen, its prevention is one of the highest priorities for those who work to make the industry safer.

The risk of drowning for commercial fisherman is high, yet most fishermen do not wear Personal Flotation Devices (PFDs) while on deck. Of the 182 fishermen who died from falls overboard between 2000 and 2011 none of them were wearing a personal flotation device (PFD). Many were within minutes of being rescued when they lost their strength and disappeared under the surface of the water.

NIOSH recently conducted a study to establish a baseline understanding of Alaska fishermen’s perceptions of risk, safety attitudes, and beliefs about PFDs; and to evaluate a variety of modern PFDs with commercial fishermen to discover the features and qualities that they like and dislike. Based upon these results, NIOSH developed an intensive risk communication strategy to raise awareness to newer (potentially more satisfactory) PFD models, to address barriers, and to encourage increased PFD use among fishermen working in Alaska.

The purpose of this study is to first, determine if fishermen’s perception of risk, safety attitudes, and beliefs about PFDs has shifted or remained the same since the implementation of the initial survey (2008–2009); and second, to evaluate the effectiveness of the NIOSH intensive risk communication intervention.